Jun 04, 2020
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
May 29, 2020
Oncolytics Biotech® Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting
May 26, 2020
Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting
May 13, 2020
Oncolytics Biotech® to Present at the RBC Global Healthcare Conference
May 08, 2020
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Apr 30, 2020
Oncolytics Biotech® Announces Changes to Annual General Meeting
Apr 17, 2020
Oncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
Apr 02, 2020
Oncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal Cancer
Mar 24, 2020
Oncolytics Biotech® Announces Favourable AWARE-1 Safety Update
Mar 05, 2020
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Mar 04, 2020
Advances in Treatments are Leading to a Decline in Deaths from Cancer
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 26, 2020
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
Jan 27, 2020
Biotech Brief: Demand is Growing for Safer, More-Efficacious Drugs When Treating Pancreatic Cancer
Jan 27, 2020
Oncolytics Biotech® Announces Statistically Significant Data Identifying CEACAM6 as a Prospective Prognostic Biomarker for Pelareorep in the Treatment of Pancreatic Adenocarcinoma
Jan 22, 2020
Oncolytics Biotech® Announces Publication of an Abstract for the 2020 Gastrointestinal Cancers Symposium Highlighting CEACAM6 as a Potential Prognostic Biomarker Candidate for Pancreatic Cancer
Jan 22, 2020
Hopeful New Therapies For Pancreatic Cancer Expected to be a Big Boon for Biotechs
Jan 21, 2020
Some U.S. Airports Begin Checking Passengers for a Deadly New Chinese Virus
Jan 15, 2020
'Guided-Missile' Cancer Drugs are the Biotech Sector's First Major Story of the 2020s